Hans Allgeier

Novartis (Switzerland) — Switzerland

Neuroscience · Life Sciences

17h-index2.2kcitations31works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroscience and Neuropharmacology Research(13), Phenothiazines and Benzothiazines Synthesis and Activities(7), Synthesis and Biological Evaluation(6), Molecular Sensors and Ion Detection(5), Phytochemistry and Bioactive Compounds(4)

Publications31 total

6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists
Bioorganic & Medicinal Chemistry Letters·2011· 22 cited
ABP688, a novel selective and high affinity ligand for the labeling of mGlu5 receptors: Identification, in vitro pharmacology, pharmacokinetic and biodistribution studies
Bioorganic & Medicinal Chemistry·2006· 71 citedOpen Access
ChemInform Abstract: 5‐Phosphonomethylquinoxalinediones as Competitive NMDA Receptor Antagonists with a Preference for the Human 1A/2A, Rather than 1A/2B Receptor Composition.
ChemInform·2002
5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition
Bioorganic & Medicinal Chemistry Letters·2002· 221 citedOpen Access
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
Neuropharmacology·1999· 720 cited
SIB-1757 and SIB-1893: Selective, Noncompetitive Antagonists of Metabotropic Glutamate Receptor Type 5
Journal of Pharmacology and Experimental Therapeutics·1999· 189 cited
[3H]CGP 61594, the first photoaffinity ligand for the glycine site of NMDA receptors
Neuropharmacology·1999· 7 cited
ChemInform Abstract: 5‐Aminomethylquinoxaline‐2,3‐diones. Part 3. Arylamide Derivatives as Highly Potent and Selective Glycine‐Site NMDA Receptor Antagonists.
ChemInform·1998
ChemInform Abstract: 5‐Aminomethylquinoxaline‐2,3‐diones. Part 2. N‐Aryl Derivatives as Novel NMDA/Glycine and AMPA Antagonists.
ChemInform·1998
Differentiation of Glycine Antagonist Sites ofN-Methyl-d-aspartate Receptor Subtypes
Journal of Biological Chemistry·1998· 53 citedOpen Access
5-aminomethylquinoxaline-2,3-diones, Part III: Arylamide derivatives as highly potent and selective glycine-site NMDA receptor antagonists
Bioorganic & Medicinal Chemistry Letters·1998· 29 citedOpen Access
5-aminomethylquinoxaline-2,3-diones. Part II: N-aryl derivatives as novel NMDA/glycine and AMPA antagonists
Bioorganic & Medicinal Chemistry Letters·1998· 25 cited
Metabotropic Glutamate Receptors: Novel Targets for Drug Development
Journal of Medicinal Chemistry·1995· 260 citedOpen Access
Profiling of trans-azetidine-2,4-dicarboxylic acid at the human metabotropic glutamate receptors mGlu1b, -2, -4a and -5a
European Journal of Pharmacology Molecular Pharmacology·1995· 27 cited
Molecular distinction of three N-methyl-D-aspartate-receptor subtypes in situ and developmental receptor maturation demonstrated with the photoaffinity ligand 125I-labeled CGP 55802A.
Proceedings of the National Academy of Sciences·1993· 31 citedOpen Access
Photoaffinity labeling of the NMDA receptor
European Journal of Pharmacology Molecular Pharmacology·1993· 3 cited
Molecular distinction of three NMDA receptor types and developmental receptor maturation demonstrated with a novel photoaffinity ligand
Max Planck Institute for Plasma Physics·1993
CGP 37849 / CGP 39551: The First Competitive NMDA Receptor Antagonists Suitable for Oral Antiepileptic Therapy
1991· 1 cited
The competitive NMDA receptor antagonists CGP 37849 and CGP 39551 are potent, orally-active anticonvulsants in rodents
Naunyn-Schmiedeberg s Archives of Pharmacology·1990· 137 cited
CGP 37849 and CGP 39551: novel and potent competitive N‐methyl‐<scp>d</scp>‐aspartate receptor antagonists with oral activity
British Journal of Pharmacology·1990· 188 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Roland Heckendorn(10), Markus Schmutz(8), Yves P. Auberson(7), Christof Angst(7), Serge Bischoff(6), Dietmar Benke(5), Silvio Ofner(5), Pierre Acklin(4), Peter J. Flor(3), Michel Biollaz(3), Stephan Urwyler(3), Aida Sacaan(3), Gönül Veliçelebi(3), Rainer Kühn(3), Kurt Lingenhoehl(3), Graham E. Fagg(3), Thomas M. Marti(3), B.M. Kapur(3), T. Reichstein(3), F. Gasparini(2)